Literature DB >> 29181484

Recruitment of At-Risk Participants for Clinical Trials: A Major Paradigm Shift for Alzheimer's Disease Prevention.

J Alber1, A K W Lee, W Menard, D Monast, S P Salloway.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 29181484     DOI: 10.14283/jpad.2017.32

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN: 2274-5807


× No keyword cloud information.
  5 in total

1.  GeneMatch: A novel recruitment registry using at-home APOE genotyping to enhance referrals to Alzheimer's prevention studies.

Authors:  Jessica B Langbaum; Jason Karlawish; J Scott Roberts; Elisabeth M Wood; Angela Bradbury; Nellie High; Trisha L Walsh; David Gordon; Raj Aggarwal; Peter Davis; Carter Stowell; Lane Trisko; Carolyn M Langlois; Eric M Reiman; Pierre N Tariot
Journal:  Alzheimers Dement       Date:  2019-02-13       Impact factor: 21.566

2.  Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer Disease Clinical Trial Recruitment.

Authors:  Mary M Ryan; Chelsea G Cox; Megan Witbracht; Dan Hoang; Daniel L Gillen; Joshua D Grill
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Apr-Jun 01       Impact factor: 2.703

3.  Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials.

Authors:  Carolyn M Langlois; Angela Bradbury; Elisabeth M Wood; J Scott Roberts; Scott Y H Kim; Marie-Emmanuelle Riviere; Fonda Liu; Eric M Reiman; Pierre N Tariot; Jason Karlawish; Jessica B Langbaum
Journal:  Alzheimers Dement (N Y)       Date:  2019-11-06

4.  Mail and Telephone Outreach from Electronic Health Records for Research Participation on Cognitive Health and Aging.

Authors:  K Pun; C W Zhu; M T Kinsella; M Sewell; H Grossman; J Neugroschl; C Li; A Ardolino; N Velasco; M Sano
Journal:  J Prev Alzheimers Dis       Date:  2021

5.  Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis.

Authors:  James D Doecke; Virginia Pérez-Grijalba; Noelia Fandos; Christopher Fowler; Victor L Villemagne; Colin L Masters; Pedro Pesini; Manuel Sarasa
Journal:  Neurology       Date:  2020-03-16       Impact factor: 9.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.